I 
118TH CONGRESS 
2D SESSION 
H. R. 7542 
To amend the Public Health Service Act to provide for congenital 
Cytomegalovirus screening of newborns. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 5, 2024 
Mr. LAWLER (for himself and Mr. LANDSMAN) introduced the following bill; 
which was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to provide for 
congenital Cytomegalovirus screening of newborns. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as ‘‘Stop CMV Act of 2024’’. 
SEC. 2. SCREENING OF CONGENITAL CYTOMEGALOVIRUS. 
Part A of title XI of the Public Health Service Act 
is amended by inserting after section 1116 (42 U.S.C. 
300b–15) the following: 
VerDate Sep 11 2014 
23:52 Mar 08, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7542.IH
H7542
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘SEC. 
1116A. 
SCREENING 
OF 
CONGENITAL 
CYTOMEGALOVIRUS. 
‘‘(a) IN GENERAL.—Each hospital or other health 
care entity caring for infants who are 21 days or less of 
age (as designated by the Secretary) may administer, or 
cause to have administered, to every such infant in its care 
a test for congenital Cytomegalovirus in accordance with 
this section. 
‘‘(b) PROCESS.— 
‘‘(1) IN GENERAL.—In carrying out this sec-
tion, the chief executive officer for health in each 
State may prescribe standards and procedures for 
the administration of testing under subsection (a), 
including recording the results of such tests, track-
ing activities, conducting follow-up reviews, and car-
rying out educational activities. 
‘‘(2) DISSEMINATION
OF
INFORMATION.—In 
carrying out this section, the chief executive officer 
for health in each State may prescribe standards 
and procedures setting forth the manner in which 
testing information is disseminated to a parent or 
guardian of the infant to be tested. 
‘‘(3) FAILURE TO PRESCRIBE.—If a State has 
not prescribed standards and procedures that are 
approved as provided for in paragraph (4) by the 
date that is 2 years after the date of enactment of 
VerDate Sep 11 2014 
23:52 Mar 08, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7542.IH
H7542
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(A) IN GENERAL.—The Secretary, acting 
through the Administrator of the Health Re-
sources and Services Administration (referred 
to in this paragraph as the ‘Secretary’), shall 
award grants to States that prescribe standards 
and procedures in accordance with paragraphs 
(1) and (2), to be distributed by the States to 
entities described in subsection (a) to admin-
ister tests in accordance with that subsection. 
‘‘(B) 
AUTHORIZATION
OF
APPROPRIA-
TIONS.—There is authorized to be appropriated 
to carry out subparagraph (A) such sums as 
may be necessary for each of fiscal years 2023 
and 2024. 
‘‘(2) CENTERS
FOR
DISEASE
CONTROL
AND 
PREVENTION.— 
‘‘(A) IN GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall award grants to, 
or enter into cooperative agreements with, 
States to provide technical assistance to State 
agencies or designated entities of States— 
‘‘(i) to develop, maintain, and improve 
data collection systems relating to con-
genital Cytomegalovirus; and 
VerDate Sep 11 2014 
23:52 Mar 08, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7542.IH
H7542
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(ii) to assist in the education and 
training of health care providers, patients, 
and the general public regarding the risk 
reduction or prevention, symptoms, diag-
nosis, 
and 
treatment 
of 
congenital 
Cytomegalovirus, including, as necessary, 
through the publication of scientific, evi-
dence-based 
educational 
materials 
on 
Internet webpages maintained by State 
agencies or designated entities of States. 
‘‘(B) 
AUTHORIZATION
OF
APPROPRIA-
TIONS.—There is authorized to be appropriated 
to carry out subparagraph (A) such sums as 
may be necessary for each of fiscal years 2023 
and 2024. 
‘‘(3) NATIONAL INSTITUTES OF HEALTH.—The 
Director of the National Institutes of Health shall— 
‘‘(A) for the purposes of this section, es-
tablish a program, or expand existing programs, 
of research and development on the efficacy of 
new screening techniques and technology relat-
ing to congenital Cytomegalovirus, including 
clinical studies of screening methods, studies on 
efficacy of intervention, and related research; 
and 
VerDate Sep 11 2014 
23:52 Mar 08, 2024
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H7542.IH
H7542
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(B) establish a program, or expand exist-
ing programs, of research and development into 
congenital Cytomegalovirus diagnostics, preven-
tion, treatments including public health aware-
ness campaigns, risk reduction, and vaccine de-
velopment, and cures or treatments (during 
pregnancy and after birth).’’. 
SEC. 3. ADVISORY COMMITTEE ON HERITABLE DISORDERS 
IN NEWBORNS AND CHILDREN. 
Section 1111(b) of the Public Health Service Act (42 
U.S.C. 300b–10(b)) is amended— 
(1) in paragraph (7) by striking ‘‘and’’ after 
the semicolon; 
(2) by redesignating paragraph (8) as para-
graph (9); and 
(3) by inserting after paragraph (7) the fol-
lowing: 
‘‘(8) carry out activities under section 1116A; 
and’’. 
Æ 
VerDate Sep 11 2014 
23:52 Mar 08, 2024
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H7542.IH
H7542
kjohnson on DSK7ZCZBW3PROD with $$_JOB